Pure Global

HUMAN GESELLSCHAFT FÜR BIOCHEMICA UND DIAGNOSTICA MBH - Authorized Company ProfileHUMAN GESELLSCHAFT FÜR BIOCHEMICA UND DIAGNOSTICA MBH

Explore comprehensive authorized company profile for HUMAN GESELLSCHAFT FÜR BIOCHEMICA UND DIAGNOSTICA MBH through Pure Global AI's free Colombia medical device database. This company manufactures 215 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Jan 31, 2024 to Dec 13, 2032.

This page provides detailed insights including recent registrations, risk class distribution (II: 148, IIa: 7, III: 33, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
215 Devices
5 Risk Classes
HUMAN GESELLSCHAFT FÜR BIOCHEMICA UND DIAGNOSTICA MBH
HUMAN GESELLSCHAFT FÜR BIOCHEMICA UND DIAGNOSTICA MBH
Authorized Company
215
Total Devices
5
Risk Classes
2024
Earliest
2032
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

HUMANEX A1C VARIANT REAGENT

HUMANEX A1C VARIANT REAGENT

b6e7fc7733b9f6d46bfa2ebb48baccac

II
Dec 13, 2032

AMH CONTROL HUMACLIA SR

AMH CONTROL HUMACLIA SR

7af370a409ce798b175c4a26eabe6f4d

II
Apr 12, 2032

FPSA HUMACLIA SR

FPSA HUMACLIA SR

21ce3318e9e09e77042b754c1686fec9

II
Apr 11, 2032

SAMPLE DILUENT B HUMACLIA SR

SAMPLE DILUENT B HUMACLIA SR

57b6dda0c667d20b49f9b1977bdbb110

I
Apr 11, 2032

IMTEC-ANA SCREEN

IMTEC-ANA SCREEN

7f6abd71b9c4aaf691de6977e7e64514

II
Jan 27, 2032

DILUENT-2

DILUENT-2

014133597dcc73479d67ff8d1aafc36a

I
Jan 11, 2032

FERRITIN CALIBRATOR

FERRITIN CALIBRATOR

570b14226ec68e2907daf6e7f58dece6

II
Jan 11, 2032

25-OH VITAMIN D HUMACLIA SR

25-OH VITAMIN D HUMACLIA SR

ad18a493388f9161a4a46aae54395765

II
Nov 26, 2031

AMH HUMACLIA SR

AMH HUMACLIA SR

e6ed0a89e88d4c32fad8e72abe9a7aa2

II
Nov 26, 2031

PCT HUMACLIA SR

PCT HUMACLIA SR

32536a0e29a29272a864e53b9dfc68b9

Nov 12, 2031

AFP HUMACLIA SR

AFP HUMACLIA SR

12e0c613b5a07339ed0181ef5e18572c

II
Nov 12, 2031

LH HUMACLIA SR

LH HUMACLIA SR

f8004999b0cd9fd69b21e7d6d378a623

II
Aug 20, 2031

T4 HUMACLIA SR

T4 HUMACLIA SR

c2784196b1239e7e605e986120134734

Aug 20, 2031

COMPLEMENT C3

COMPLEMENT C3

7b07ed43e504eecca7da5c5fb505b3d1

II
Aug 20, 2031

RHEUMATOID FACTORS

RHEUMATOID FACTORS

5abc2ea1a0cd25e47b2c65cdaf87c684

Aug 20, 2031

ANTI-TG HUMACLIA SR

ANTI-TG HUMACLIA SR

8c2a43c7f68fc21d8032a3895c1674e4

Aug 20, 2031

COMPLEMENT C4

COMPLEMENT C4

600441c0de204213aaa64c1de5c15355

Aug 20, 2031

ANTI-TPO HUMACLIA SR

ANTI-TPO HUMACLIA SR

48e465e7ecafe7c7a486c05bf31dad71

Aug 20, 2031

K FILLING SOLUTION

K FILLING SOLUTION

debc5b0674bd2025eb2796dd608a7bd8

Aug 12, 2031

REAGENT PACK HUMALYTE PLUS 3

REAGENT PACK HUMALYTE PLUS 3

98292d5b426b11f7de46efcf791d2f8f

II
Aug 12, 2031
Risk Class Distribution
Devices by risk class
II
148
68.8% of total
III
33
15.3% of total
Unspecified
23
10.7% of total
IIa
7
3.3% of total
I
4
1.9% of total